Co-Authors
This is a "connection" page, showing publications co-authored by DONALD YEE and BRADY MOFFETT.
Connection Strength
1.790
-
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
Score: 0.562
-
Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
Score: 0.556
-
Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
Score: 0.142
-
Warfarin-Rifampin Drug Interaction in a Pediatric Patient. J Pediatr Pharmacol Ther. 2017 Sep-Oct; 22(5):375-377.
Score: 0.140
-
Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis. J Pediatr. 2015 Sep; 167(3):645-9.
Score: 0.120
-
Evaluation of weight-based dosing of unfractionated heparin in obese children. J Pediatr. 2013 Jul; 163(1):150-3.
Score: 0.102
-
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.
Score: 0.099
-
A Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in Children. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2):128-133.
Score: 0.039
-
Use of 4-Factor Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric Patients. Ann Pharmacother. 2016 Jan; 50(1):70-1.
Score: 0.031